| Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2018: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2017: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2016: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
|
|---|
| Outline of Final Research Achievements |
This research mainly focused on below 3 points;1)seeking feasible IP law system for realizing "fascinating harmony" between active promotion of generic phamaceuticals to accomplish medical and healthcare political goals and innovative promotion of newly developing phamaceuticals,2)analyzing theoretical and institutional factors for IP law system to accelerate innovation of "personalized medicine" technology,3)alleviating negative effects for medical treatments caused by enforcement of IP rights in the fields of phamaceuticals and medical technology. As the outcomes of this research,some directional views of above 3 points to evolve well- harmonized IP law system with political goals and technological innovations.
|
